Navigating Bias in AI-Driven Cancer Detection
Researchers highlight the risks of biased AI in cancer detection and propose strategies to ensure fair, effective, and equitable healthcare.
Read MorePosted by Andy Lundin | Nov 12, 2024 | Cancer |
Researchers highlight the risks of biased AI in cancer detection and propose strategies to ensure fair, effective, and equitable healthcare.
Read MorePosted by Andy Lundin | Nov 12, 2024 | Molecular Diagnostics, Prostate |
A genetic variant in the PSA gene may help improve prostate cancer diagnostics by distinguishing between aggressive and non-aggressive types.
Read MorePosted by Andy Lundin | Nov 8, 2024 | Sequencing Systems |
A study reveals that while diagnostic accuracy in genetic testing is consistent across racial groups, access disparities persist.
Read MorePosted by Andy Lundin | Nov 8, 2024 | Cancer |
The NCCN updated its Clinical Practice Guidelines to broaden genetic testing recommendations for high-risk cancer types.
Read MorePosted by Andy Lundin | Nov 6, 2024 | Colorectal |
Multitarget stool DNA testing is a highly sensitive, non-invasive method for colorectal cancer screening, offering a colonoscopy alternative.
Read More